Pursuant to the regulation 30 of the SEBI Listing Regulations, Medicamen Biotech has informed that the Company has been informed by the RTA that they have changed their name from Link Intime India to MUFG Intime India with effect from December 31, 2024. The company has informed to take note of the same and update the name as ‘MUFG Intime India’ as the RTA of the Company, in the records. The address and other contact details of the RTA of the Company remain unchanged. The Certificate of Incorporation reflecting the name change of the RTA, as received from the RTA, is enclosed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: